Streetbeat News

TRUMY

Terumo Corporation

https://www.terumo.co.jp/

CEO

Shinjiro Sato

Industry

Surgical and Medical Instrument Manufacturing

Open

19.55

Mkt cap

29B

Volume

3.1K

High

19.64

P/E Ratio

37.75

52-wk high

20.59

Low

19.55

Div yield

N/A

52-wk low

14.06

Needham initiated coverage on Inari Medical Inc (NARI) with a Buy rating and a price target of $72, citing its leadership in the venous thrombectomy market and potential as an acquisition target. Inari Medical's products, FlowTriever and ClotTriever, target markets with a combined TAM of $5.8 billion. The company was also noted for its robust gross margin, double-digit revenue growth, and recent acquisition of LimFlow SA. Potential acquirers include major medical technology firms like Abbott Laboratories, Becton, Dickinson and Co, Boston Scientific, Medtronic, Philips, Stryker, Teleflex, and Terumo. Inari Medical's shares are considered attractively valued, trading at a premium compared to peers.

Portfolio Pulse from Vandana Singh

January 23, 2024 | 7:56 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.